Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409825 · ClinicalTrials.gov registry record · Phase 2
Study of Pharmacology of 17-OHPC in Pregnancy
A Phase 2 study of Pregnancy, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
- 4
- Study locations
NCT00409825 is a Phase 2 study of Pregnancy that has completed, run by University of Pittsburgh. The registered enrollment target is 61 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00409825, a Phase 2 study of Pregnancy, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
- 4
- Study locations
Study Summary
We are examining the pharmacology of 17-OHPC in pregnancy, specifically between the second and third trimesters.
Conditions Studied
Interventions
- DRUG 17-OHPC
- PROCEDURE Blood Draws
Study Locations (4)
District of Columbia
- Georgetown University - Washington D.C.
Pennsylvania
- Magee-Womens Hospital of University of Pittsburgh Medical Center - Pittsburgh
Texas
- University of Texas - Galveston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-03 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00409825
The ClinicalTrials.gov registry entry for NCT00409825 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which 17-OHPC is the first listed.
NCT00409825 reports 4 study locations spanning 4 distinct geographic areas - top geographies include District of Columbia, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT00409825 about?
NCT00409825 is a clinical study titled "Study of Pharmacology of 17-OHPC in Pregnancy". We are examining the pharmacology of 17-OHPC in pregnancy, specifically between the second and third trimesters.
What is the current status of trial NCT00409825?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2006-03. Estimated completion is 2014-02.
What conditions does trial NCT00409825 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT00409825?
The interventions under investigation include: 17-OHPC (DRUG), Blood Draws (PROCEDURE).
Who is sponsoring clinical trial NCT00409825?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00409825 being conducted?
This trial has 4 study locations across District of Columbia, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
RECRUITING · Phase 2
-
Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women
COMPLETED · Phase 2
-
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
COMPLETED · Phase 2
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.